In brief, what’s happening at Penn—whether it’s across campus or around the world.
On February 17, nurses from Penn Nursing and Penn Medicine shared their true, personal stories for Penn Nursing’s third annual Story Slam event. Due to the current guidelines and restrictions around the pandemic, the event was held virtually, but that did not lessen the impact or vibrancy of the storytellers and their tales, developed around the theme, “Stepping Up.”
FULL STORY AT Penn Nursing News →
A direct-to-consumer blood test for a key Alzheimer’s biomarker may be inevitable, but Penn Program on Precision Medicine for the Brain researchers Jason Karlawish, Emily Largent, and Anna Wexler warn that receiving results from such a test comes with potential challenges. The team weigh the risks and benefits of these blood tests in an article for JAMA Neurology titled “The Future is p-Tau—Anticipating Direct-to-Consumer Alzheimer’s Disease Blood Tests.”
FULL STORY AT Penn Memory Center →
The gift provides financial aid to support approximately half of the high school juniors and seniors who are selected to participate in the program, guaranteeing that applicants can join the program on the basis of their talent and potential as writers.
FULL STORY AT Penn Arts & Sciences →
The associate dean for the natural sciences and professor of psychology has been selected as the 2021 recipient of the award from the OSA for his experimental and theoretical contributions to our understanding of how the visual system resolves the ambiguities inherent in sensory signals to produce a stable percept of object color.
FULL STORY AT Penn Arts & Sciences →
The Center for Soft and Living Matter will be a joint endeavor between the School of Arts & Sciences and the School of Engineering and Applied Science, led by director Andrea J. Liu, Hepburn Professor of Physics, and associate director Douglas J. Durian, professor of physics.
FULL STORY AT Penn Arts & Sciences →
A new study may explain how brain dysfunction gives rise to sleep disruptions in children with neurodevelopmental disorders.
FULL STORY AT Penn Medicine News →
A Phase 3 clinical trial shows that Avacopan, which targets a receptor that attracts the cells that cause inflammation, was shown to be more effective at keeping patients in remission for a year than prednisone.
FULL STORY AT Penn Medicine News →
The Failure Analysis of Engineering Materials course went online during the Fall 2020 semester, successfully providing real-world engineering examples, such as bridge collapses or construction crane failures, to help students understand why a given material has broken.
FULL STORY AT Penn Engineering Today →
Two new research grant programs have been launched in partnership with the Center for Innovation & Precision Dentistry to help advance innovative breakthroughs in dental medicine, with Penn Health-Tech and the Penn Medicine Center for Health Care Innovation incorporating these funding opportunities into their annual call for proposals for medical devices and health technology development projects.
FULL STORY AT Penn Dental Medicine →
The Epilepsy Monitoring Unit and the Human Neurophysiology Research Laboratory at the new Pavilion at the Hospital of the University of Pennsylvania is a twelve bed unit will be equipped with cameras, recording equipment, and monitor–advanced imaging to help find where seizures coming from in the brain.
FULL STORY AT Penn Medicine News →
